Loading…
Strata Critical Medical, Inc. is projected to rise to $8.14 by 2027, a +30% move from its current price of $6.26. SRTA is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $6.08 | $6.26 | $6.45 | -0.01% |
| May 30 | $6.00 | $6.26 | $6.53 | -0.01% |
| May 31 | $5.94 | $6.26 | $6.59 | -0.02% |
| Jun 1 | $5.89 | $6.26 | $6.64 | -0.03% |
| Jun 2 | $5.85 | $6.26 | $6.69 | -0.04% |
| Jun 3 | $5.82 | $6.26 | $6.73 | -0.04% |
| Jun 4 | $5.78 | $6.26 | $6.77 | -0.05% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $5.78 | $6.26 | $6.77 | -0.05% |
| Week 2 | $5.59 | $6.25 | $6.99 | -0.10% |
| Week 3 | $5.45 | $6.25 | $7.17 | -0.15% |
| Week 4 | $5.33 | $6.25 | $7.32 | -0.20% |
| Week 5 | $5.23 | $6.24 | $7.45 | -0.25% |
| Week 6 | $5.14 | $6.24 | $7.58 | -0.30% |
| Week 7 | $5.06 | $6.24 | $7.69 | -0.35% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States. It operates in two segments, Logistics and Clinical, reflecting a dual focus on transportation and clinical support for organ logistics and related medical materials.
Strata Critical Medical, Inc. (SRTA) currently trades at $6.13 per share and has a market capitalization of $530.41M. It is ranked 2996 by market cap.
A major floor 37.7% below — a decisive break under it would weaken the trend.
The nearest floor, 28.3% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 18.8% above — clearing it would confirm fresh momentum.
Key SRTA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SRTA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $5.97 | Buy | $6.00 | Buy |
| MA 10 | $5.66 | Buy | $5.77 | Buy |
| MA 20 | $5.43 | Buy | $5.49 | Buy |
| MA 50 | $4.81 | Buy | $5.08 | Buy |
| MA 100 | $4.87 | Buy | $4.89 | Buy |
| MA 200 | $4.81 | Buy | $4.69 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 72.28 | Sell |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 175.56 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.07 | Buy |
| ROC (12) | 12.39 | Buy |
| Bollinger %B (20,2) | 1.01 | Sell |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.82 | Buy |
| Awesome (5,34) | 0.89 | Buy |
| Ultimate (7,14,28) | 81.05 | Sell |
| Momentum (10) | 0.79 | Buy |
| Aroon Osc (25) | 92.00 | Buy |
| Hull MA (9) | 6.32 | Sell |
| ADX (14) | 27.14 | Buy |
| ATR (14) | 0.16 | Info |
The 30-day technical picture is bullish, with RSI14 at 70. The stock sits above the support level of $4.12 and below the resistance at $6.13; the 30-day price range runs from $4.98 to $7.55. The moving averages show SMA50 at $4.75 and SMA200 at $4.79, indicating a near-term uptrend alongside an annualized volatility of 60%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.04 | $6.26 | $8.15 | 0% | Neutral | |
| $6.39 | $8.14 | $11.00 | +30% | Bullish | |
| $8.18 | $10.73 | $15.08 | +71% | Bullish | |
| $9.15 | $12.31 | $17.83 | +97% | Bullish | |
| $9.75 | $13.41 | $19.94 | +114% | Bullish | |
| $10.10 | $14.18 | $21.55 | +126% | Bullish | |
| $11.15 | $15.95 | $24.75 | +155% | Bullish | |
| $11.79 | $17.18 | $27.15 | +174% | Bullish | |
| $13.51 | $20.03 | $32.18 | +220% | Bullish | |
| $17.14 | $25.83 | $42.16 | +313% | Bullish | |
| $21.43 | $34.83 | $60.67 | +456% | Bullish | |
| $40.28 | $74.69 | $143.09 | +10.9x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $4.04 | $6.26 | $7.36 | +0.00% |
| June 2026 | $5.22 | $6.15 | $7.42 | -1.80% |
| July 2026 | $5.24 | $6.22 | $7.61 | +1.17% |
| August 2026 | $5.36 | $6.42 | $7.94 | +3.19% |
| September 2026 | $5.22 | $6.28 | $7.85 | -2.07% |
| October 2026 | $5.02 | $6.07 | $7.65 | -3.39% |
| November 2026 | $5.11 | $6.22 | $7.89 | +2.36% |
| December 2026 | $5.22 | $6.38 | $8.15 | +2.59% |
Click any year to see its month-by-month SRTA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect SRTA to range from $4.04 to $8.15 through 2026. The $6.26 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The SRTA price prediction for 2027 points to an average of $8.14 (low $6.39, high $11.00) — a potential gain of +30% on today's $6.26. Momentum favours further upside here.
In 2028, SRTA is projected to trade between $8.18 and $15.08, averaging $10.73 — a potential gain of +71% from today's $6.26. That is up +32% on the projected 2027 average. Buyers look set to stay in control over this stretch.
Strata Critical Medical, Inc.'s 2029 outlook centres on $12.31, within a $9.15 to $17.83 range. That is up +15% on the projected 2028 average. That marks a +97% change versus current levels. Momentum favours further upside here.
By 2030, SRTA could reach as high as $19.94, with a base case around $13.41 and support toward $9.75 — roughly +114% from $6.26. Buyers look set to stay in control over this stretch.
Expect SRTA to range from $10.10 to $21.55 through 2031. The $14.18 average target implies a +126% move from current prices. That is up +6% on the projected 2030 average. Momentum favours further upside here.
The SRTA price prediction for 2032 points to an average of $15.95 (low $11.15, high $24.75) — a potential gain of +155% on today's $6.26. Buyers look set to stay in control over this stretch.
In 2033, SRTA is projected to trade between $11.79 and $27.15, averaging $17.18 — a potential gain of +174% from today's $6.26. That is up +8% on the projected 2032 average. Momentum favours further upside here.
Strata Critical Medical, Inc.'s 2034 outlook centres on $20.03, within a $13.51 to $32.18 range. That is up +17% on the projected 2033 average. That marks a +220% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, SRTA could reach as high as $42.16, with a base case around $25.83 and support toward $17.14 — roughly +313% from $6.26. Momentum favours further upside here.
Expect SRTA to range from $21.43 to $60.67 through 2040. The $34.83 average target implies a +456% move from current prices. That is up +35% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The SRTA price prediction for 2050 points to an average of $74.69 (low $40.28, high $143.09) — a potential gain of +10.9x on today's $6.26. Momentum favours further upside here.
Investing $1,000 in SRTA today (≈ 159.744409 SRTA) could be worth
$11,931.05
+$10,931.05 (+1093%) by 2050 · US Dollar
Based on the average projected SRTA price of $74.69 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SRTAwould be worth at today's price.
$1,000 invested in SRTA on May 27, 2025 (≈ 283.286121 SRTA) would be worth
$1,773.37
+$773.37 (+77.3%) today · 1.77× · US Dollar
Based on a SRTA entry price of $3.53 vs. today's $6.26.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $5.54 | $1,129.96 | +13.0% |
| 1 month ago | $4.95 | $1,264.65 | +26.5% |
| 3 months ago | $4.43 | $1,413.09 | +41.3% |
| 6 months ago | $4.34 | $1,442.4 | +44.2% |
| 1 year ago | $3.53 | $1,773.37 | +77.3% |
| All time (5.0y) ago | $9.96 | $628.51 | -37.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SRTA forecast.
Our base-case forecast reaches $13.00 around 2030.
Implied market cap at $13.00: $1.12B
The multi-year forecast shows ongoing upside with a bullish tone into the late 2020s and beyond. In 2026 the average price is $6.13 with a min of $4.04 and a max of $8.01 and a neutral sentiment (ROI 0). From 2027 onward, the forecast envisions rising averages and bullish sentiment, including 2027 avg $8.05 (ROI 31.4%), 2028 avg $10.82 (ROI 76.5%), 2029 avg $12.26 (ROI 100%), and 2030 avg $13.39 (ROI 118.5%).
The longer horizon shows substantial upside, with 2035 avg $26.27 (ROI 328.6%), 2040 avg $35.68 (ROI 482%), and 2050 avg $76.12 (ROI 1141.8%), all labeled bullish.
Tap a question to reveal the answer.
In 2030, the forecast shows an average price of $13.39, with a min of $9.63 and a max of $20.16, and a ROI of 118.5%. Sentiment is BULLISH.
The forecast shows bullish sentiment from 2027 onward with rising averages and positive ROI (e.g., 2027 ROI 31.4%, 2028 ROI 76.5%, 2030 ROI 118.5%, 2050 ROI 1141.8%). However, these are estimates and not guarantees, and 2026 is Neutral with ROI 0.
The forecast max values include 2035 max $43.59, 2040 max $63.34, and 2050 max $149.10. Therefore, reaching $100 is within the forecast by 2050, but not in earlier years.
Current price is $6.13 and market cap is $530.41M.
RSI14 is 70; SMA50 is $4.75; SMA200 is $4.79; support is $4.12 and resistance is $6.13. The 30-day range is $4.98 to $7.55, and annualized volatility is 60%.
Strata Critical Medical, Inc. Community Discussion
0Share your Strata Critical Medical, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.